NCT00115583View on ClinicalTrials.gov

The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Atherosclerosis, Coronary
Interventions
DRUG

Drug Infusion (BQ-123)

Trial Locations (1)

02115

Brigham and Womens Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT00115583 - The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries | Biotech Hunter | Biotech Hunter